ESR1 and breast cancer: Indeed, at the time of diagnosis, breast cancer classification and choice of adjuvant treatment still rely on traditional pathological parameters and immunoisthochemical (IHC) analysis of three main markers (ER, PR and HER2), which divide breast cancer into Luminal, HER2 positive, and Triple Negative Breast Cancer [56].